Cutler Group LLC / CA - INOVIO PHARMACEUTICALS INC ownership

INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 174 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.29 and the average weighting 0.0%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of INOVIO PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$1
-100.0%
1,400
-56.2%
0.00%
Q3 2022$8,000
+14.3%
3,200
+39.1%
0.00%
Q2 2022$7,000
+40.0%
2,300
-20.7%
0.00%
Q1 2022$5,000
-98.7%
2,900
-97.0%
0.00%
-100.0%
Q4 2021$395,000
+153.2%
95,245
+892.1%
0.02%
+142.9%
Q3 2021$156,000
-3.7%
9,600
-5.0%
0.01%0.0%
Q2 2021$162,000
-0.6%
10,100
+14.8%
0.01%
-12.5%
Q1 2021$163,000
-6.9%
8,800
-21.6%
0.01%0.0%
Q4 2020$175,000
-25.8%
11,231
-74.9%
0.01%
-42.9%
Q3 2020$236,000
-78.1%
44,800
-71.7%
0.01%
-80.6%
Q2 2020$1,080,000
+99.3%
158,100
-55.0%
0.07%
+157.1%
Q1 2020$542,000
+54100.0%
351,128
+26909.8%
0.03%
Q1 2018$1,0000.0%1,300
-13.3%
0.00%
Q4 2017$1,000
-97.2%
1,500
-95.7%
0.00%
-100.0%
Q3 2017$36,000
-37.9%
34,650
+17.8%
0.00%
-50.0%
Q2 2017$58,000
+286.7%
29,414
-3.9%
0.00%
+100.0%
Q1 2017$15,000
-61.5%
30,600
-64.3%
0.00%0.0%
Q4 2016$39,000
-49.4%
85,596
+48.1%
0.00%
-75.0%
Q3 2016$77,000
-45.4%
57,796
-56.2%
0.00%
-42.9%
Q2 2016$141,000
-19.4%
131,996
+40.6%
0.01%
-41.7%
Q1 2016$175,000
+13.6%
93,870
+89.0%
0.01%
+50.0%
Q4 2015$154,00049,6540.01%
Other shareholders
INOVIO PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Green Alpha Advisors, LLC 570,049$221,7490.17%
GMT CAPITAL CORP 1,513,500$588,7520.02%
Cedar Brook Financial Partners, LLC 130,522$50,7730.01%
Arlington Capital Management, Inc. 27,735$10,7890.01%
GSA CAPITAL PARTNERS LLP 296,948$1160.01%
Keystone Financial Group 109,897$42,7510.01%
Hennion & Walsh Asset Management, Inc. 163,562$63,6260.00%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,149,974$447,3400.00%
Freedom Investment Management, Inc. 62,298$24,2340.00%
Renaissance Technologies 4,889,500$1,9020.00%
View complete list of INOVIO PHARMACEUTICALS INC shareholders